Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sectra ABCHIX:SECTBS 98 EV-to-EBITDA is 61.61 as of Jul. 19, 2026, which is 16% above its 10-year median of 53.23. GuruFocus rates CHIX:SECTBS with a GF Score™ of 98/100 and a GF Value™ of kr310.49 (Modestly Undervalued). Among 510 Medical Devices & Instruments companies, Sectra AB ranks worse than 90.98% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sectra AB's enterprise value is kr51,291 Mil.
Sectra AB's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 was kr832 Mil. Therefore, Sectra AB's EV-to-EBITDA for today is 61.61.
The historical rank and industry rank for Sectra AB's EV-to-EBITDA or its related term are showing as below:
CHIX:SECTBs'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 18.23 Med: 53.23 Max: 96.15
Current: 61.61
During the past 13 years, the highest EV-to-EBITDA of Sectra AB was 96.15. The lowest was 18.23. And the median was 53.23.
CHIX:SECTBs's EV-to-EBITDA is ranked worse than 90.98% of 510
companies
in the Medical Devices & Instruments industry
Industry Median: 14.155
vs CHIX:SECTBs: 61.61
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Sectra AB (CHIX:SECTBs) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sectra AB's share price for today is kr277.30.
Sectra AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2.930.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Sectra AB's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SECTBS vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Sectra AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sectra AB's EV-to-EBITDA falls into.
Sectra AB's current Enterprise Value is kr51,291 Mil.
Sectra AB's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr832 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sectra AB (CHIX:SECTBS) has a EV-to-EBITDA of 61.61 as of Jul. 19, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Sectra AB. This is 16% above median its historical median of 53.23. Over the past decade, Sectra AB's EV-to-EBITDA has ranged from 18.23 to 96.15. According to the industry distribution chart, Sectra AB ranks #464 out of 510 companies in the Medical Devices & Instruments industry, placing it in the top 91%.
Is Sectra AB's EV-to-EBITDA too high?
Sectra AB's current EV-to-EBITDA of 61.61 is 16% above median its 10-year median of 53.23. Over the past 10 years, this metric has ranged from a low of 18.23 to a high of 96.15. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.16. Sectra AB's value of 61.61 is 335.3% above this industry median. Based on the distribution chart, Sectra AB ranks #464 out of 510 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sectra AB has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #464 out of 510 companies for EV-to-EBITDA. This places Sectra AB in the lower half of its industry. The industry median EV-to-EBITDA is 14.16. Sectra AB's value of 61.61 is 335.3% above this benchmark. Historically, Sectra AB's own EV-to-EBITDA has ranged from 18.23 to 96.15 over the past decade. While the company's 10-year median is 53.23 vs. the industry median of 14.16, Sectra AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.16, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current EV-to-EBITDA of 61.61 is 335.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Sectra AB. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current EV-to-EBITDA is 61.61, which is 16% above median its own 10-year median of 53.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (CHIX:SECTBS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr310.49, compared to a current price of kr277.30 — trading 10.7% below its estimated fair value. The current EV-to-EBITDA is 61.61, which is 16% above median its 10-year median of 53.23 and 335.3% above the Medical Devices & Instruments industry median of 14.16. Sectra AB's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Sectra AB (CHIX:SECTBS), the current EV-to-EBITDA is 61.61 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (CHIX:SECTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of kr277.30 is trading 10.7% below its estimated GF Value™ of kr310.49.
GuruFocus considers Sectra AB to be Modestly Undervalued.
Key valuation signals for CHIX:SECTBS:
EV-to-EBITDA: 61.61 (16% above median its 10-year median of 53.23)
GF Value™: kr310.49 vs. price of kr277.30 (10.7% below fair value)
Industry Position: 335.3% above the Medical Devices & Instruments median (#464 of 510)
No single metric tells the full story. See the CHIX:SECTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
98GF Score
Get the complete analysis for CHIX:SECTBS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SECTBS has been successfully added to your 
